Web Analytics

3 Latest Announced Rounds

  • $250,000,000
    Series B

    1 Investors

    Software Development
    Nov 5th, 2025
  • $8,000,000
    Series A

    3 Investors

    Technology, Information and Internet
    Nov 5th, 2025
  • $6,000,000
    Seed

    3 Investors

    Software Development
    Nov 5th, 2025
$1,217.57M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Azalea Therapeutics

start up
United States - Berkeley, California
  • 05/11/2025
  • Series A
  • $82,000,000

Azalea Therapeutics is a biotechnology company redefining precision genomic medicines in vivo. Its proprietary Enveloped Delivery Vehicles (EDV) platform is engineered to deliver transient CRISPR-Cas9 cargo to specific cells in the body for site-specific genome editing with curative intent. Azalea’s first programs leverage T cell-targeting EDVs and highly efficient T cell-tropic AAVs to enable programmable CAR gene insertion at a defined genomic locus, placing expression under control of the cell’s endogenous promoter for physiologic and sustained activity. This approach aims to generate potent, durable and safe therapies directly inside patients, avoiding the complexity of ex vivo manufacturing and unlocking new treatment modalities – including in vivo CAR-T cell therapies – across cancer, autoimmune disease and genetic disorders. Azalea is headquartered in Berkeley, California. For more information, please visit azaleatx.com and follow us here on LinkedIn.


Related People

Jenny HamiltonCo Founder

Jenny Hamilton United States - Berkeley, California

We've entered the era of genomic medicine, where gene addition, modification, or disruption can cure genetic-driven diseases. However, the delivery of molecular tools to specific cells or organs is a major obstacle to realizing the potential of genome engineering. I'm leveraging my background in virology to enable the safe & effective delivery of genome editors for therapeutic applications.

More about me on the IGI website: https://innovativegenomics.org/news/meet-an-igi-scientist-jennifer-hamilton/